IIT Roorkee Discovery: Cysteine Sabotage Kills Superbugs

Scientists at IIT Roorkee have identified a significant metabolic weakness in Acinetobacter baumannii, a notorious bacterium responsible for severe hospital-acquired infections. This superbug's resistance to antibiotics has posed a growing global health challenge.

The research, published in mBio, focused on the bacterium's cysteine metabolism. Cysteine is vital for bacterial survival, playing roles in enzyme function and stress management. The study found that by disrupting the bacterium's ability to produce or take up cysteine, its survival mechanisms are severely impaired.

Researchers observed that disabling cysteine pathways led to metabolic imbalances, reduced energy production, and increased oxidative stress within the bacteria. This made the weakened pathogens substantially more vulnerable to existing antibiotics. A key finding was "synthetic lethality," achieved by blocking both cysteine biosynthesis and uptake, which proved fatal to the bacteria.

Experiments using mouse models demonstrated that cysteine-deficient strains were more easily eradicated by antibiotics, and the bacteria caused less lung damage. This metabolic targeting strategy offers a promising complementary approach to conventional antibiotic therapies. The findings highlight innovative pathways for developing new treatments against multidrug-resistant A. baumannii.